TFF Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$21,243,231 and profit margin reached -2895%. Total operating expenses were $22,628,533.
Profit Margin
| 2017 | 0 | -178.60K | |
|---|---|---|---|
| 2019 | 0 | -11.75M | |
| 2020 | 0 | -18.44M | |
| 2021 | 0 | -30.98M | |
| 2022 | 0 | -31.77M | |
| 2023 | 733.87K | -21.24M | -2894.68% |
TFFP Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 733.87K | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 502.48K | 388.22K | 111.45K | 0 | 0 | 0 |
Gross profit | 231.39K | -388.22K | -111.45K | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 11.55M | 18.49M | 21.30M | 10.68M | 8.82M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.62M | 31.79M | 31.78M | 18.69M | 11.98M | 178.60K |
Operating income | -21.89M | -31.79M | -31.78M | -18.69M | -11.98M | -178.60K |
Other income (expenses), net | 651.43K | 26.72K | 747.94K | 126.41K | 117.32K | 0 |
Income before tax | -21.24M | -31.77M | -31.03M | -18.56M | -11.87M | -178.60K |
Income tax expense | 0 | -26 | -51.23K | -126.41K | -117.32K | -52.52K |
Net income | -21.24M | -31.77M | -30.98M | -18.44M | -11.75M | -178.60K |
Earnings per share | ||||||
Basic EPS | -11.85 | -26.49 | -31.21 | -22.57 | -42.55 | -0.01 |
Diluted EPS | -11.85 | -26.49 | -31.21 | -22.57 | -42.55 | -0.01 |
| Data source | Data source | Data source | Data source | Data source |